Accrued Liabilities, Current of Regencell Bioscience Holdings Ltd from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Regencell Bioscience Holdings Ltd quarterly Accrued Liabilities, Current in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
  • Regencell Bioscience Holdings Ltd Accrued Liabilities, Current for the quarter ending 30 Jun 2025 was $348,354, a 178% increase year-over-year.
Source SEC data
View on sec.gov
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $348,354 +$223,026 +178% 30 Jun 2025 20-F 31 Oct 2025 2025 FY
Q2 2024 $125,328 -$32,753 -21% 30 Jun 2024 20-F 31 Oct 2025 2025 FY
Q2 2023 $158,081 +$6,954 +4.6% 30 Jun 2023 20-F 25 Oct 2024 2024 FY
Q2 2022 $151,127 -$421,863 -74% 30 Jun 2022 20-F 27 Oct 2023 2023 FY
Q2 2021 $572,990 +$477,990 +503% 30 Jun 2021 20-F 31 Oct 2022 2022 FY
Q2 2020 $95,000 30 Jun 2020 20-F 29 Oct 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.